76 related articles for article (PubMed ID: 18172308)
1. Expression of CDK4 or CDK2 in mouse oral cavity is retained in adult pituitary with distinct effects on tumorigenesis.
Macias E; Miliani de Marval PL; Senderowicz A; Cullen J; Rodriguez-Puebla ML
Cancer Res; 2008 Jan; 68(1):162-71. PubMed ID: 18172308
[TBL] [Abstract][Full Text] [Related]
2. CDK2 activation in mouse epidermis induces keratinocyte proliferation but does not affect skin tumor development.
Macias E; Miliani de Marval PL; De Siervi A; Conti CJ; Senderowicz AM; Rodriguez-Puebla ML
Am J Pathol; 2008 Aug; 173(2):526-35. PubMed ID: 18599613
[TBL] [Abstract][Full Text] [Related]
3. Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis.
Macias E; Kim Y; Miliani de Marval PL; Klein-Szanto A; Rodriguez-Puebla ML
Cancer Res; 2007 Oct; 67(20):9713-20. PubMed ID: 17942901
[TBL] [Abstract][Full Text] [Related]
4. MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2.
Gillam MP; Nimbalkar D; Sun L; Christov K; Ray D; Kaldis P; Liu X; Kiyokawa H
Oncogene; 2015 Feb; 34(7):932-8. PubMed ID: 24531709
[TBL] [Abstract][Full Text] [Related]
5. p27kip1 Regulates cdk2 activity in the proliferating zone of the mouse intestinal epithelium: potential role in neoplasia.
Smartt HJ; Guilmeau S; Nasser SV; Nicholas C; Bancroft L; Simpson SA; Yeh N; Yang W; Mariadason JM; Koff A; Augenlicht LH
Gastroenterology; 2007 Jul; 133(1):232-43. PubMed ID: 17631145
[TBL] [Abstract][Full Text] [Related]
6. HMGA2 cooperates with either p27
Fedele M; Paciello O; De Biase D; Monaco M; Chiappetta G; Vitiello M; Barbieri A; Rea D; Luciano A; Papparella S; Arra C; Fusco A
Cell Cycle; 2018; 17(5):580-588. PubMed ID: 29157111
[TBL] [Abstract][Full Text] [Related]
7. Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo.
Berton S; Pellizzari I; Fabris L; D'Andrea S; Segatto I; Canzonieri V; Marconi D; Schiappacassi M; Benevol S; Gattei V; Colombatti A; Belletti B; Baldassarre G
Cell Cycle; 2014; 13(19):3100-11. PubMed ID: 25486569
[TBL] [Abstract][Full Text] [Related]
8. Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53.
Padmakumar VC; Aleem E; Berthet C; Hilton MB; Kaldis P
Mol Cell Biol; 2009 May; 29(10):2582-93. PubMed ID: 19307310
[TBL] [Abstract][Full Text] [Related]
9. p27Kip1 and p21Cip1 collaborate in the regulation of transcription by recruiting cyclin-Cdk complexes on the promoters of target genes.
Orlando S; Gallastegui E; Besson A; Abril G; Aligué R; Pujol MJ; Bachs O
Nucleic Acids Res; 2015 Aug; 43(14):6860-73. PubMed ID: 26071952
[TBL] [Abstract][Full Text] [Related]
10. Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues.
Miliani de Marval PL; Macias E; Rounbehler R; Sicinski P; Kiyokawa H; Johnson DG; Conti CJ; Rodriguez-Puebla ML
Mol Cell Biol; 2004 Sep; 24(17):7538-47. PubMed ID: 15314163
[TBL] [Abstract][Full Text] [Related]
11. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
Upton JW; van Dyk LF; Speck SH
Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis.
Reddy HK; Mettus RV; Rane SG; Graña X; Litvin J; Reddy EP
Cancer Res; 2005 Nov; 65(22):10174-8. PubMed ID: 16288002
[TBL] [Abstract][Full Text] [Related]
13. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
Martín A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
[TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
Said TK; Moraes RC; Singh U; Kittrell FS; Medina D
Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
[TBL] [Abstract][Full Text] [Related]
15. A confederacy of kinases: Cdk2 and Cdk4 conspire to control embryonic cell proliferation.
Hinds PW
Mol Cell; 2006 May; 22(4):432-3. PubMed ID: 16713571
[TBL] [Abstract][Full Text] [Related]
16. CDK4 activity in mouse embryos expressing a single D-type cyclin.
Ciemerych MA; Yu Q; Szczepanska K; Sicinski P
Int J Dev Biol; 2008; 52(2-3):299-305. PubMed ID: 18311721
[TBL] [Abstract][Full Text] [Related]
17. Removal of Cdk inhibitors through both sequestration and downregulation in zearalenone-treated MCF-7 breast cancer cells.
Ahamed S; Foster JS; Bukovsky A; Diehl JA; Wimalasena J
Mol Carcinog; 2002 May; 34(1):45-58. PubMed ID: 12112322
[TBL] [Abstract][Full Text] [Related]
18. Bottom-up cell proliferation with cyclin A and p27Kip1 expression in ulcerative colitis-associated dysplasia.
Mikami T; Yoshida T; Shiraishi H; Tokuyama W; Motoori T; Okayasu I
Pathol Int; 2006 Jan; 56(1):10-6. PubMed ID: 16398674
[TBL] [Abstract][Full Text] [Related]
19. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E
Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654
[TBL] [Abstract][Full Text] [Related]
20. Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity.
Sotillo R; Renner O; Dubus P; Ruiz-Cabello J; Martín-Caballero J; Barbacid M; Carnero A; Malumbres M
Cancer Res; 2005 May; 65(9):3846-52. PubMed ID: 15867383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
